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AbstrACt
Introduction South Asians have high rates of 
cardiovascular disease (CVD) and its risk factors 
(hypertension, diabetes, dyslipidaemia and central obesity). 
Left ventricular (LV) hypertrophy and dysfunction are 
features of these disorders and important predictors of 
CVD mortality. Lower birth and infant weight and greater 
childhood weight gain are associated with increased 
adult CVD mortality, but there are few data on their 
relationship to LV function. The IndEcho study will examine 
associations of birth size, growth during infancy, childhood 
and adolescence and CVD risk factors in young adulthood 
with midlife cardiac structure and function in South Asian 
Indians.
Methods and analysis We propose to study 
approximately 3000 men and women aged 43–50 years 
from two birth cohorts established in 1969–1973: the 
New Delhi Birth Cohort (n=1508) and Vellore Birth Cohort 
(n=2156). They had serial measurements of weight and 
height from birth to early adulthood. CVD risk markers 
(body composition, blood pressure, glucose tolerance 
and lipids) and lifestyle characteristics (tobacco and 
alcohol consumption, physical activity, socioeconomic 
status) were assessed at age ~30 years. Clinical 
measurements in IndEcho will include anthropometry, 
blood pressure, biochemistry (glucose, fasting insulin 
and lipids, urinary albumin/creatinine ratio) and body 
composition by dual energy X-ray absorptiometry and 
bioelectrical impedance. Outcomes are LV mass and 
indices of LV systolic and diastolic function assessed by 
two-dimensional and Doppler echocardiography, carotid 
intimal-media thickness and ECG indicators of ischaemia. 
Regression and conditional growth models, adjusted for 
potential confounders, will be used to study associations 
of childhood and young adult exposures with these 
cardiovascular outcomes.
Ethics and dissemination The study has been approved 
by the Health Ministry Steering Committee, Government of 
India and institutional ethics committees of participating 
centres in India and the University of Southampton, UK. 
Results will be disseminated through scientific meetings 
and peer-reviewed journals.
trial registration number ISRCTN13432279; Pre-results.
IntroduCtIon  
background and rationale
The emerging epidemic of cardiovascular 
disease (CVD) in transitioning populations 
means that low/middle-income countries 
strengths and limitations of this study
 ► The strengths include the longitudinal study design 
with early growth data, which allows examination 
of the relationship of size at birth, childhood growth 
and cardiovascular disease risk markers in young 
adult life with myocardial structure and function in 
midlife in South Asians.
 ► The two cohorts represent both rural and urban pop-
ulations, north and south India and diverse socio-
economic strata.
 ► The study will use harmonised methods to measure 
anthropometry, biochemical risk factors and to char-
acterise lifestyle factors.
 ► A limitation of the study is attrition of the cohorts due 
to deaths and migration (mainly in childhood).
 ► Because this is a field-based study, echocardiog-
raphy will be used, rather than cardiac MRI, which 
is the current gold standard method for measuring 
myocardial structure.
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(LMICs) contribute a larger proportion to the global 
burden of CVD (~8–9 million deaths per year) than 
high-income countries (~5 million).1–3 Migrants from 
LMICs to high-income countries experience an excess 
of CVD compared with indigenous populations.4–6 A 
parallel increase in the prevalence of hypertension, type 
2 diabetes (T2DM) and obesity, which are known risk 
factors for CVD is also observed in LMICs.7 8 
Altered myocardial structure and function have 
received less attention as causes of cardiac death than 
ischaemic heart disease (IHD). Left ventricular hyper-
trophy (LVH) increases the future risk of heart failure 
and death9 through volume overload, pressure overload 
and myocyte loss.10 11 LVH is usually asymptomatic for 
several years before the development of congestive heart 
failure. Obesity, hypertension, T2DM and IHD initiate LV 
remodelling and dysfunction and enhance progression to 
heart failure.11 12 The prospective Coronary Artery Risk 
Development in (Young) Adults (CARDIA) study showed 
that higher blood pressure, body mass index (BMI), waist 
circumference, cholesterol, triglyceride and glucose 
concentrations at age 18–30 years are risk factors for LV 
diastolic dysfunction 5–10 years later.13 However, these 
traditional risk factors explain less than half the vari-
ability in echocardiographic parameters in population 
studies.14 15
South Asians develop CVD and T2DM, often in combi-
nation, a decade earlier than white Caucasians.16 17 Several 
factors contribute to this premature disease: (1) lifestyle 
changes (the adoption of less healthy diets and reductions 
in physical activity, consequences of rapid socioeconomic 
transition), (2) a characteristic pattern of risk factors (low 
high-density lipoprotein (HDL) cholesterol, elevated 
lipoprotein (a) and high insulin resistance)18 19 and 
(3) a ‘thin-fat’ body composition (low muscle mass but 
centrally adipose),19 20 the latter two being evident even 
at birth.21 22
South Asian newborns have a low mean birth weight 
(2.6–2.7 kg) compared with white Caucasian babies21 23 
and frequently show suboptimal growth and weight gain 
during infancy.24 Low birth and infant weight are risk 
factors for CVD mortality in adult life and have also been 
linked to a high risk of hypertension and T2DM.25 26 It 
has been suggested that these associations reflect ‘devel-
opmental programming’, permanent structural and 
functional deficits in key metabolic organs (eg, liver, 
pancreas and kidneys) and tissues (eg, muscle) resulting 
from impaired nutrition during fetal and early child-
hood development.27 Studies in India have linked lower 
birth weight to higher blood pressure, serum lipids and 
abnormal glucose tolerance in children and adults.28–30 
The risks associated with lower birth weight appear to 
be increased on subsequent exposure to greater child 
or adult weight gain. Upward crossing of BMI centiles in 
childhood and adolescence is associated with increases in 
several CVD risk factors such as higher adult cholesterol, 
triglyceride and proinflammatory marker concentrations 
and with an increased risk of obesity, impaired glucose 
tolerance or T2DM (figure 1), hypertension and meta-
bolic syndrome.29 31
Figure 1 BMI SD scores from birth to adulthood for participants in each cohort who developed IGT or diabetes (n=219/1562 
in NDBC and 424/2218 in VBC) in adult life relative to the whole cohort (dashed zero line). BMI, body mass index; IGT, impaired 
glucose intolerance; NDBC, New Delhi Birth Cohort; VBC, Vellore Birth Cohort.
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Early life factors may also influence cardiac structure 
and function. Growth restricted fetuses and newborns 
have impaired LV function,32–34 thought to be caused 
by hypoxia, raised placental resistance and altered fetal 
circulation.35 Studies relating birth weight to adolescent 
or adult LV size, in a variety of populations, have shown 
a positive association36 or a non-significant inverse associ-
ation.37 38 In the latter two studies, low weight in infancy 
was associated with higher adult LV mass and concentric 
LVH. Several studies have shown that higher childhood 
BMI is associated with higher LV mass in childhood and 
adult life and an increased risk of adult LVH.36 39 40
There are few population-based data on the preva-
lence of echocardiographic abnormalities among South 
Asians. Indian migrants to the UK present with heart 
failure younger than white British men and women.41 
The echocardiographic imaging of healthy individuals 
in the UK London Life Sciences Prospective Population 
(LOLIPOP) study showed that South Asians have poorer 
diastolic function, threefold higher prevalence of LVH 
and a greater degree of concentric remodelling.42 The 
UK Southall And Brent REvisited Study (SABRE) study 
showed that the impact of hyperglycaemia on LV mass 
and function was more adverse in South Asians.15 One 
previous Indian study has investigated LV mass in relation 
to birth size; it found low mean LV mass compared with 
white Caucasian populations and an association of longer 
birth length with higher adult LV mass.43 44
Thus, several factors along the life course are related 
to adult LV hypertrophy and dysfunction, including 
greater adiposity, longer duration of adiposity, higher 
blood pressure and lipids, impaired glucose tolerance 
and early-life growth patterns (figure 2). The current 
IndEcho study was designed to investigate these rela-
tionships in two large population-based Indian birth 
cohorts.
Hypotheses
 ► The prevalence of LVH and LV dysfunction and 
carotid intimal-media thickness (cIMT) will be posi-
tively related to current midlife cardiometabolic risk 
factors;
Figure 2 Pathways to altered left ventricular (LV) structure and function that will be investigated in IndEcho. Factors 
contributing to LV hypertrophy. Intrauterine undernutrition alters the fetal circulation, which may have direct and persistent 
effects on ventricular structure. Intrauterine and infant undernutrition impairs the development of key metabolic tissues (muscle, 
pancreas, liver, blood vessels and kidneys) during critical periods of growth and increases adipose tissue deposition, leading to 
the ‘thin-fat’ phenotype and later obesity, T2DM, dyslipidaemia, hypertension and chronic renal disease, which adversely impact 
on LV size and function. BMI, body mass index; LV, left ventricular; T2DM, type 2 diabetes mellitus.
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 ► After adjusting for current cardiometabolic risk 
factors, LVH, LV dysfunction and cIMT will be posi-
tively related to cardiometabolic risk factors measured 
12–16 years ago in young adulthood;
 ► LVH, LV dysfunction and higher cIMT will be associ-
ated with lower birth weight, lower weight in infancy 
(the first two postnatal years) and faster BMI gain 
during childhood and adolescence;
 ► The associations of LVH, LV dysfunction and cIMT 
with adult cardiometabolic risk factors will be stronger 
in men and women who had lower birth or infant 
weight.
MEtHods And AnAlysIs
study design
Multicentre observational cohort study.
study population
The IndEcho study started in November 2016 and will 
continue until 2019. Participants will be recruited from 
two Indian birth cohorts: the New Delhi Birth Cohort 
(NDBC)29 45 and Vellore Birth Cohort (VBC).46 Both were 
established in 1969–1973, originally to study maternal 
health and pregnancy outcomes. The participants were 
measured at various time points through infancy, child-
hood, adolescence and early adulthood to assess growth 
and were subsequently followed up at approximately 
30 and 40 years of age to measure a range of CVD risk 
markers. Flow charts of the different stages of follow-up 
and various measurements are provided in figure 3. 
Currently, the participants are aged 43–50 years and new 
cases of glucose intolerance, T2DM and hypertension 
are emerging alongside rapid transitions in lifestyle and 
socioeconomic status (SES). For the IndEcho study, we 
aim to recruit approximately 3000 individuals from both 
cohorts combined.
the ndbC
In 1969–1972, 20 755 married women of reproductive 
age living in a 12 km2 area of South Delhi were recruited 
(figure 3). The cohort included 8181 singleton live 
births from 9169 pregnancies among these women. 
Gestational age was derived from last menstrual period 
(LMP) dates. The birth weight, length and head circum-
ference of the babies were recorded within 72 hours of 
birth (n=7119) and thereafter 3 monthly up to the age 
of 12 months (n=4104) and 6 monthly until the age of 21 
years (n=2892). An average 23 sets of measurements were 
recorded for each individual from birth until 21 years. The 
first adult study took place in 1998–2002; 2584 (32%) of 
the original cohort were retraced, of whom 1526 men and 
women (then aged 28–31 years) participated in a study of 
CVD risk factors.29 Data on their SES, attained education, 
family history of disease, tobacco and alcohol consump-
tion, diet and physical activity were obtained using stan-
dardised questionnaires. Clinical measurements included 
anthropometry, blood pressure, an ECG and analysis of 
plasma glucose (during an oral glucose tolerance test), 
insulin, lipids and proinflammatory markers. In 2008 (at 
age 34–39 years), the same measurements were repeated 
in 1100 cohort members and additionally, cIMT and 
brachial artery endothelial function were measured47 
and body composition was assessed using dual-energy 
Figure 3 Flow chart of various stages of follow-up of the New Delhi and Vellore Birth cohorts and measurements recorded 
at each stage. BMI, body mass index; DXA, dual energy X-ray absorptiometry; HC, hip circumference; OGTT, oral glucose 
tolerance test; PA, physical activity; SES, socioeconomic status.
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X-ray absorptiometry (DXA) in a subset. Excluding 18 
known deaths (from a total of 1526 who were followed up 
during 1998–2002), we aim to recruit as many as possible 
of the 1508 alive NDBC participants.
the VbC
From 1969–1973, 20 626 women of reproductive age 
were recruited within defined areas of Vellore town and 
adjoining rural villages in Tamil Nadu, in South India48 
(figure 3). The areas of Vellore town were selected to 
represent different socioeconomic groups. The cohort 
comprised 10 691 singleton live babies born to the 20 626 
women recruited. Weight and length were recorded at 
birth (n=10 676) and subsequently in infancy (in the first 
3 months, n=5753), childhood (6–8 years, n=5541) and 
adolescence (10–15 years, n=2672). Gestational age was 
determined from the mother’s LMP dates. Depending on 
available funding, VBC members had up to 3 measure-
ments in the first 3 months, up to 2 measurements 
between 6 and 8 years and up to 5 measurements between 
10 and 15 years. The first adult follow-up took place in 
1998–2002. Cohort members for whom all birth measure-
ments were available (n=4092) were retraced to partic-
ipate in an adult follow-up during 1998–2002. Of these 
2572 were contactable, and 2218 men and women, then 
aged 26–32 years, consented to participate in the study. 
CVD risk factors were assessed using a similar protocol 
to that for NDBC.49 Subsequently in 2013–2014, 1080 
participants (50.1% urban), aged 41–45 years, took part 
in a body composition study, in which the same anthropo-
metric and biochemical parameters were recorded along 
with detailed body composition using DXA. Excluding 62 
known deaths (from a total of 2218 who were followed up 
during 1998–2002), we aim to recruit as many as possible 
of the 2156 alive VBC members.
The total number of participants in phases 1 and 2 of 
adult follow-up in the NDBC and VBC and reasons for 
losses to follow-up are summarised in online supplemen-
tary table 1. We will minimise loss to follow-up through 
the following algorithm until all non-responders are 
accounted for: telephone calls/postal letters, meet-
ings with neighbours by field workers and contact with 
local municipality/postal services to track addresses of 
migrated individuals.
Measurements in the IndEcho study
Measurements will include anthropometry (height, 
weight, waist and hip circumferences, skinfold thickness), 
body composition by DXA (Vellore only) and bioelectrical 
impedance, hand grip strength, blood pressure, biochem-
ical measurements (an oral glucose tolerance test, fasting 
plasma insulin and lipids and urinary albumin/creatinine 
ratio, as a measure of microalbuminuria). Details of the 
methods used for these measurements are given in table 1. 
Lifestyle factors (tobacco and alcohol consumption, diet, 
physical activity, occupation and SES) will be reassessed. 
Standard questionnaires for diet (food frequency ques-
tionnaire),50 SES (Standard of Living Index),51–53 Global 
Table 1 IndEcho study procedures and platforms used
Study-related procedures Methods/platforms used
Questionnaire assessments
  Diet FFQ
  Physical activity GPAQ
  Socioeconomic status NFHS Standard of Living 
Index
  Smoking NFHS-2 Household 
Questionnaire
  Alcohol consumption NFHS-2 Household 
Questionnaire
Anthropometry
  Height Stadiometer
  Weight Digital weighing scales
  Waist circumference Non-stretchable tape
  Hip circumference Non-stretchable tape
  Blood pressure Omron M3
Biochemistry
  Glucose—fasting Enzymatic method 
(autoanalyser)
  Glucose—120 min Enzymatic method 
(autoanalyser)
  Insulin—fasting Vellore: Radiofluorimetric 
method
  Cholesterol Delhi: Chemiluminescence 
immunoassay
CHOD-PAP Enzymatic 
colorimetric method
  Triglycerides GPO-PAP Enzymatic 
colorimetric method
  HDL cholesterol Direct—two-step enzymatic
  LDL cholesterol Direct—enzymatic 
colorimetric method
  Urinary ACR Jaffe Method
Skinfold thickness John Bull/Harpenden skinfold 
calliper
Bioimpedence Tanita BC-418/Bodystat
2500
Hand grip JAMAR dynamometer
DXA Hologic Discovery
ECG
Echocardiography Philips CX50 Compact 
Xtreme system
cIMT Philips CX50 Compact 
Xtreme system
FFQ developed by the National Institute of Nutrition, Hyderabad.51 
SES Questionnaire developed by NFHS-2, 1998–1999.52
GPAQ developed by WHO.53
ACR, albumin-creatinine ratio; cIMT, carotid intimal- media 
thickness; DXA, dual energy X-ray absorptiometry; FFQ, Food 
Frequency Questionnaire; GPAQ, Global Physical Activity 
Questionnaire; HDL, high-density lipoprotein; LDL, low-density 
lipoprotein; NFHS, National Family Health Survey; SES, 
socioeconomic status. 
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Physical Activity Questionnaire,54 55 smoking and alcohol 
consumption56 will be used. Details on the key covariates 
relating to life style are summarised in online supplemen-
tary table 2.
Impaired glucose tolerance, impaired fasting glucose 
and T2DM will be diagnosed based on fasting glucose 
concentration and glucose concentration 120 min after a 
75 g oral glucose load, using WHO criteria.57 Hyperten-
sion will be defined as systolic pressure >140 mm Hg or 
diastolic pressure >90 mm Hg or on treatment for hyper-
tension.58 We will use International Diabetes Federation 
criteria for the following outcomes59: overweight and 
obesity: BMI >25 and >30 kg/m2, respectively; central 
obesity: a waist circumference >90 cm in men and >80 cm 
in women; hypertriglyceridaemia: plasma triglyceride 
concentration >1.7 mmol/L and low HDL choles-
terol:<1.03 mmol/L in men and <1.29 mmol/L in women.
Echocardiography
Cardiac chamber dimensions and systolic and diastolic 
function will be assessed using transthoracic echocardi-
ography. All measurements will be performed according 
to the American and European Societies for Echocardi-
ography guidelines for chamber quantification60 61 and 
left ventricular diastolic function.62 The same machine 
(Philips CX50 Compact Xtreme, Bothell, USA) and trans-
ducer (C5-1 Purewave curved array transducer) will be 
used in both centres and images will be analysed using 
the Freeland digitiser and software packages (Alpharetta, 
USA). M-mode and two-dimensional (2D) echocardiog-
raphy in the parasternal long axis, midpapillary short axis 
and apical two-chamber and four-chamber views will be 
used to measure relative wall thickness (RWT; an index of 
wall thickness relative to internal dimensions). LVH will 
be defined based on any one of the following criteria: (1) 
LV mass >150 g in women and >200 g in men; (2) poste-
rior wall thickness >1.1 cm or (3) LV mass indexed to 
body surface area (BSA) >95 g/m2 in women and 115 g/
m2 in men.61 Concentric LVH, which is an independent 
CVD risk factor, particularly in hypertensive patients, will 
be defined as increased RWT >0.42 in the presence of 
normal LV mass. LV systolic dysfunction will be assessed 
using measurements of fractional shortening, ejection 
fraction and global longitudinal strain (GLS). Ejec-
tion fraction will be measured using Simpson’s biplane 
method in apical 2 and 4 chamber views. GLS will be 
calculated offline using speckle-tracking technology from 
the acquired 2D; two-chamber, three-chamber and four-
chamber views using the in-built QLAB software in the 
CX50 echo machine. LV diastolic dysfunction will be 
assessed using mitral valve inflow velocities, mitral annular 
tissue Doppler velocities, left atrial volume index and 
tricuspid regurgitation jet velocity as per the guidelines.62
Scans will be performed by experienced echo techni-
cians, two per centre, after a joint 2-day protocol-specific 
training session. Following this, the technical quality of 
scans will be checked by the senior cardiologist locally 
in each centre, and a set of 10 scans will be exchanged 
between centres for an independent quality assessment. 
Scans will be read by experienced cardiologists in each 
centre (AR in New Delhi and VTS and AGA in Vellore). 
A random 10% of all scans recorded in the study will be 
exchanged and read by the other centre to assess interob-
server variability.
cIMt measurement
Measurements of cIMT will be made bilaterally using 
high-resolution B-mode ultrasound with the same 
machine (Philips CX50 Compact Xtreme) and a 10-MHz 
linear array probe (Philips) and quantified using the 
CX50-IMT Philips Quantification application according 
to American Society for Echocardiography guidelines.63 
Each common carotid artery will be imaged in three 
different projections (anterior, lateral and posterior) 
proximal to the bifurcation. Measurements of IMT will be 
taken at a plaque-free zone in the far wall of the common 
carotid artery, captured at the end of diastole. The mean 
of three readings will be taken. The presence or absence 
of plaque, defined as a focal structure that encroaches on 
the arterial lumen by at least 0.5 mm or is more than 50% 
of the surrounding IMT or has a thickness greater than or 
equal to 1.5 mm will also be recorded. Between measurer 
reproducibility in the LV parameters and cIMT will be 
assessed by the exchange of 10% of scans from each site.
ECG
All participants will undergo a 12-lead ECG recording. 
ECGs will be reviewed by a cardiologist, and if there are 
changes suggestive of ischaemia (ST-depression and/or 
T wave inversion), detailed Minnesota Coding will be 
performed. We will use Minnesota codes 1–1  and  1–2, 4–1 
and 4 –2, 5–1 and 5–2 and 7–1 to indicate ischaemic heart 
disease.64
body composition assessments
Body composition (total lean mass, fat mass and fat 
per cent) will be assessed using bioelectrical impedance in 
both centres (Tanita BC-418 in NDBC and Bodystat-2500 
in VBC). In VBC, a DXA examination will be additionally 
performed (Hologic Discovery) to obtain total and depot 
specific lean mass, fat mass and total fat percentage. DXA 
body composition analysis was assessed among NDBC 
participants in 200965 and will not be re-examined in 
IndEcho.
A copy of the full protocol can be obtained from the 
corresponding author.
sample size and analysis
We will target the surviving cohort members (1508 
from NDBC and 2156 from VBC) who participated in 
follow-ups between 1998 and 2002. From initial tracing in 
early 2016, a total of 3500 individuals were recontacted, 
among whom we expect approximately 1250 in Delhi and 
1750 in Vellore to participate (total 3000) in the current 
protocol.
Exposures in early life will include weight and length 
at birth: weight, height and BMI and independent 
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conditional weight and height estimates of growth 
during infancy, childhood and adolescence, as previously 
described.48 Because early growth measurements were 
measured at different time points and at slightly different 
ages in both cohorts, and owing to the skewness of BMI, 
the data will be transformed into SD scores using the 
lambda-mu-sigma (LMS) method.66 The main analysis 
will use all available data at each time point; it will also 
be repeated using the subset of participants having data 
for all time points (birth, infant, childhood and adoles-
cent measurements). Exposures in young adult life will 
include lifestyle characteristics (diet, physical activity, 
smoking and alcohol consumption, SES, urban/rural 
residence and history of rural–urban migration (Vellore 
only)), anthropometry, lean and fat mass measured by 
DXA and bioimpedance, metabolic risk markers (plasma 
glucose, insulin and lipids) and categorical abnormalities 
as defined above.
We will check the distributions of all variables and 
perform appropriate transformations. We will explore 
relationships between LV wall thickness and mass (as 
continuous variables) with current body size and make 
appropriate adjustments, including the conventional 
adjustment for body surface area and height.60 We will 
create categorical variables to represent LVH and ventric-
ular dysfunction based on standard cut-offs for LV mass as 
described above.61 We will examine associations of early 
life and young adult exposures with outcomes, using 
Table 2 Comparison of early growth measurements of studied and not-studied participants during phase 1 adult follow-up
Measurement
New Delhi birth cohort Vellore birth cohort
Male Female Male Female
Studied as adult Studied as adult Studied as adult Studied as adult
Yes No Yes No Yes No Yes No
Birth
  n 808 2642 569 2497 1159 1712 1058 1741
  Weight (kg) 2.89±0.44 2.86±0.46 2.79±0.38 2.78±0.44 2.85±0.53 2.83±0.61 2.78±0.5 2.76±0.54
  Length (cm) 48.8±2.2 48.7±2.4 48.3±1.9 48.1±2.2 48.3±3.0 47.8±4.6 47.8±3.0 47.3±4.3
  Ponderal index 
(kg/m3)
24.8±2.6 24.7±2.9 24.7±2.5 24.9±2.9 25.7±7.6 25.6±7.3 25.7±6.6 25.9±7.3
  Gestation (week) 39.2±2.2 39.2±2.3 39.6±2.0 39.6±2.2 38.2±2.8 38.1±2.9 38.3±2.8 38.4±2.8
Infancy (3 months)
  n 660 2140 503 2105 845 1011 791 1108
  Weight (kg) 5.50±0.7 5.46±0.8 4.96±0.7 4.99±0.7 4.28±0.8 4.17±0.9 4.04±0.7 3.91±0.8
  Height (cm) 59.6±2.4 59.5±2.7 58.0±2.4 58.1±2.5 55.2±3.1 55.1±3.6 54.3±2.9 54.2±3.2
  BMI (kg/m2) 15.4±1.5 15.4±1.6 14.7±1.6 14.7±1.6 14.1±1.9 13.6±2.2 13.6±1.7 13.12±1.92
Childhood (6 years)
  n 837 1092 608 1219 1001 601 933 645
  Weight (kg) 17.2±2.2 17.3±2.3 16.4±2.0 16.5±2.2 15.8±4.4 15.5±4.4 15.4±4.3 15.4±4.2
  Height (cm) 108.4±5.2 108.9±5.5 107.0±5.1 107.2±5.5 102.4±18.7 100.1±26.4 100.6±19.7 100.6±23.5
  BMI (kg/m2) 14.6±1.1 14.5±1.1 14.3±1.1 14.3±1.2 15.4±4.4 15.3±4.1 15.6±4.8 15.2±4.11
Adolescence 
(15 years)
  n 616 435 481 592 775 467 727 508
  Weight (kg) 44.6±9.2 45.8±9.6 44.6±7.8 44.2±7.5 27.7±5.8 27.5±6.3 28±5.37 28.5±6.1
  Height (cm) 159.2±8.7 160.2±8.4 153.2±5.7 153.3±6.2 136.5±9.9 137.1±13.6 135.3±8.0 136.5±9.9
  BMI (kg/m2) 17.5±2.5 17.7±2.7 18.9±3.0 18.8±2.7 14.7±1.4 14.6±1.6 15.2±1.9 15.2±1.8
Adulthood
  n 886 — 640 — 1159 — 1053
  Age (years) 29.2±1.3 — 29.2±1.4 — 27.9±1.1 — 28.3±1.2 — 
  Weight (kg) 71.8±14.0 — 59.2±13.4 — 57.4±11.4 — 49.3±10.6 — 
  Height (cm) 169.7±6.4 — 154.9±5.7 — 166.4±6.7 — 153.8±6.0 — 
  BMI (kg/m2) 24.9±4.3 — 24.6±5.1 — 20.7±3.5 — 20.8±4.1 — 
BMI, body mass index.
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linear and logistic regression as appropriate, with and 
without adjustment for potential confounders and covari-
ates (including age, sex, history of migration, current 
body size and composition). We will also use the condi-
tional growth modelling approach to relate growth in 
BMI and height during discrete age periods with adult 
outcomes.67 68 We will explore interactions between early 
life and young adult exposures and between early life 
exposures and current measures, using product terms. 
The role of young adult lifestyle and CVD risk markers 
as mediators of associations between early-life exposures 
and outcomes will also be examined. To test the repre-
sentativeness of the IndEcho participants and assess 
the risk of bias, we will compare their early growth vari-
ables (birth length, birth weight and height, weight and 
BMI in infancy, childhood and early adulthood) with 
members of the original cohorts who did not participate 
as we have done previously (table 2). Since all analyses in 
the IndEcho study will be ‘internal’ (within the sample 
of participants) bias will occur only if the associations 
between early growth and adult outcomes differ between 
those who participate in IndEcho and those who were not 
studied. We cannot think of a mechanism by which such 
differences could occur. We will examine the data from 
men and women, from Delhi and Vellore and (in Vellore) 
among rural and urban participants separately and assess 
heterogeneity of associations and scope for pooling.
Using tests at 5% significance and a total sample size 
of 3000, we will have 80% power to detect an association 
of 0.05 SDs of a continuous outcome (eg, LV mass) per 
SD change in a continuous predictor (eg, birth weight 
or conditional weight gain in infancy). For the Vellore 
cohort alone (based on n=1750), this figure is 0.07 SDs 
and for the Delhi cohort alone (based on n=1250), it is 
0.08 SDs. These figures compare favourably with the asso-
ciation shown between infant weight and adult LV mass 
in the Hertfordshire cohort (0.17 SD per SD change in 
infant weight).26 For a binary outcome such as LV diastolic 
dysfunction (Grades 1 and 2), assuming 10% prevalence 
and a test at 5% significance level, we will have 80% power 
to detect an association of 0.17 log odds per SD change 
in a continuous predictor, equivalent to an OR of 1.19 
(Vellore 1.25, Delhi 1.30).
dIsCussIon
To the best of our knowledge, IndEcho will be the first 
study among South Asians to provide data linking birth 
size and childhood growth, as well as prior measures of 
CVD risk markers and lifestyle factors such as physical 
activity and smoking in young adulthood, with cardiac 
structure and function and in middle age. It will provide 
an opportunity to study interactions between early life, 
young adult and concurrent risk factors in relation to 
myocardial outcomes.
The main strengths of the study are that it includes 
participants from two large Indian birth cohorts that have 
serial childhood growth data, measured prospectively by 
trained research staff and risk factors for CVD (including 
lifestyle risk factors) assessed 16–20 years ago. Harmon-
ised methods will be used in both cohorts. The partici-
pants represent north and south Indian populations, 
different socioeconomic strata and rural and urban 
settings. Because we have serial measures of SES, 
collected using identical methods, IndEcho provides an 
opportunity to assess the impact of economic transition 
on cardiac health in Indians. At this age, we will detect 
subclinical cardiac disease in an apparently healthy popu-
lation where obesity, hypertension and T2DM are esca-
lating. In 1998–2002 at age 26–32 years, the prevalence of 
obesity (BMI >30 kg/m2), hypertension (systolic >140 mm 
Hg or diastolic >90 mm Hg or on treatment for hyperten-
sion) and diabetes (WHO criteria) was 11%, 8% and 4%, 
respectively, in NDBC29 and 2%, 3% and 3% in VBC.31 
Approximately 5 years later, at 34–39 years, the preva-
lence had more than doubled in NDBC (23%, 26% and 
9%).45 In the 2013–2014 VBC follow-up, the equivalent 
data (16%, 20% and 17%) showed a more than fivefold 
increase in prevalence in just over a decade (unpublished 
data).
Like all birth cohorts of this age, an important limita-
tion is loss to follow-up, mainly due to deaths in childhood 
and migration out of the original study area. However, 
current cohort members were similar in early life to 
the rest of the original cohorts (table 2).29 48 To create 
bias, the relationship between the predictors (eg, birth 
weight or young adult diabetes) and outcomes (eg, LV 
mass) would have to differ between those studied and not 
studied. Another limitation is that, because this is a field-
based study, echocardiography will be used rather than 
cardiac MRI which is the current gold standard method 
for measuring myocardial structure.
The findings of the IndEcho study will help plan effec-
tive strategies in early life and/or young adulthood to 
prevent adult CVD in India and migrant South Asian 
populations. We expect that it will identify periods during 
early life when nutritional interventions may prevent later 
cardiac disease. As the prospective follow-up continues in 
future and as cohort members start to develop cardiac 
disease, we will also be able to define the value of LV 
measurements for predicting cardiovascular morbidity 
and mortality, which will be the first such data from India.
EtHICs And dIssEMInAtIon
IndEcho does not involve any invasive or risky proce-
dures for participants. Participant information sheets and 
consent forms are made available in English and local 
languages, describing the purpose of the study and the 
various procedures in lay terms. Participation is voluntary 
and participants provide written informed consent before 
enrolment. Findings from the study will be disseminated 
through presentations at both international and national 
conferences and results generated will be published in 
international peer-reviewed journals.
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